The Incidence and Alliance of Metabolic Syndrome with Cardiovascular Risk Markers among Kodavas


Background: Metabolic syndrome is the major cause for life threatening disorders such as cardiovascular diseases and type 2 diabetes. These disorders are associated with hyperuricemia and the number is growing among the urban population. Methods: A cross sectional study was done among Kodava population by conducting health camps in Mysore district. Metabolic syndrome was defined according to Joint Interim Statement criteria. Anthropometry was done and blood pressure readings were noted. Clinical markers like fasting glucose, triglyceride, high density lipoprotein, CVD markers and uric acid levels were analyzed. Results: The prevalence of metabolic syndrome was 60.77% and the utmost occurrence was in 41 - 60 age groups. Women were more affected than men (31.58%) and MetS became pronounced with advance of age. Biochemical levels of C-reactive protein, ApolipoproteinB/ApolipoproteinA1 ratio and uric acid wereraised (P < 0.05) and the severity correlated with the number of components of metabolic syndrome. Conclusions: This study helped in identifying new subjects with metabolic syndrome wherein, abdominal obesity was the most common abnormality followed by elevated fasting glucose. Female subjects and subjects with increased waist circumference along with mid aged people are more susceptible to MetS which amplified their CVD risk factors and hyperuricemic conditions. Life style modifications and therapeutic approach are critical prerequisite. However, there is an urgent need for further health camps for the awareness, and prevention of MetS and its associated risk factors among Kodavas.

Share and Cite:

Lokanath, D. , Chandrashekariah, S. , Xaviour, D. and Rao, J. (2014) The Incidence and Alliance of Metabolic Syndrome with Cardiovascular Risk Markers among Kodavas. Open Journal of Endocrine and Metabolic Diseases, 4, 158-166. doi: 10.4236/ojemd.2014.46016.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Grundy, S.M. (2006) Metabolic Syndrome. Connecting and Reconciling Cardiovascular and Diabetes Worlds. Journal of American College Cardiology, 47, 1093-1100.
[2] Amano, T., Matsubara, T. and Uetani, T. (2007) Impact of Metabolic Syndrome on Tissue Characteristics of Angiographically Mild to Moderate Coronary Lesions Integrated Backscatter Intravascular Ultrasound Study. Journal of American College Cardiology, 49, 1149-1156.
[3] Iribarren, C., Alan, S.G, Gail, H. and Stephen, S. (2006) Metabolic Syndrome and Early-Onset Coronary Artery Disease: Is the Whole Greater Than Its Parts? Journal of American College Cardiology, 48, 1800-1807.
[4] Misra, A., Misra, R., Wijesuriya, M. and Banerjee, D. (2007) The Metabolic Syndrome in South Asians: Continuing Escalation and Possible Solutions. Indian Journal of Medical Research, 125, 345-354.
[5] Singh, K.S. (2003) Anthropological Survey of India, People of India. Anthropological Survey of India.
[6] Muthanna, I.M. (1971) The Coorg Memoirs (The Story of the Kodavas). Usha Press, Vellore.
[7] Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I. and Donato, K.A. (2009) Harmonizing the Metabolic Syndrome. Circulation, 120, 1640-1645.
[8] Misra, A., Chowbey, P., Makkar, B.M., Vikram, N.K., Wasir, J.S. and Chadha, D. (2009) Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the Metabolic Syndrome for Asian Indians and Recommendations for Physical Activity, Medical and Surgical Management. Journal of Association Physicians India, 57, 163-170.
[9] Misra, A. and Khurana, L. (2008) Obesity and the Metabolic Syndrome in Developing Countries. Journal of Clinical Endocrinology and Metabolism, 93, S9-S30.
[10] Prasad, D.S., Kabir, Z. and Das, B.C. (2012) Prevalence and Risk Factors for Metabolic Syndrome in Asian Indians: A Community Study from Urban Eastern India. Journal of Cardiovascular Disease Research, 3, 204-211.
[11] Ramachandran, A., Snehalatha, C., Satyavani, K., Sivasankari, S. and Vijay, V. (2003) Metabolic Syndrome in Urban Asian Indian Adults—A Population Study Using Modified ATP III Criteria. Diabetes Research and Clinical Practice, 60, 199-204.
[12] Pemminati, S., Prabha Adhikari, M.R., Pathak, R. and Pai, M.R. (2010) Prevalence of Metabolic Syndrome (METS) Using IDF 2005 Guidelines in a Semi Urban South Indian (Baloor Diabetes Study) Population of Mangalore. Journal of Association Physicians of India, 58, 674-677.
[13] Das, M., Pal, S. and Ghosh, A. (2010) Association of Metabolic Syndrome with Obesity Measures, Metabolic Profiles, and Intake of Dietary Fatty Acids in People of Asian Indian Origin. Journal of Cardiovascular Disease Research, 1, 130-135.
[14] Deepa, M., Farooq, S., Datta, M., Deepa, R. and Mohan, V. (2007) Prevalence of Metabolic Syndrome Using WHO, ATPIII and IDF Definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metabolism Research Review, 23, 127-134.
[15] Kaushik, P., Soumik, G. and Subhankar, C. (2012) Metabolic Syndrome in South Asians. Indian Journal of Endocrinology Metabolism, 16, 44-55.
[16] Sawant, A., Mankeshwar, R., Shah, S., Raghavan, R., Dhongde, G., et al. (2011) Prevalence of Metabolic Syndrome in Urban India. Cholesterol, 2011, Article ID: 920983.
[17] Kinra, S., Bowen, L.J., Lyngdoh, T., Prabhakaran, D., Reddy, K.S., Ramakrishnan, L., et al. (2010) Sociodemographic Patterning of Non-Communicable Disease Risk Factors in Rural India: A Cross Sectional Study. British Medical Journal, 341, c4974.
[18] Gupta, A., Gupta, R., Sarna, M., Rastogi, S., Gupta, V.P. and Kothari, K. (2003) Prevalence of Diabetes, Impaired Fasting Glucose and Insulin Resistance Syndrome in an Urban Indian Population. Diabetes Research and Clinical Practice, 61, 69-76.
[19] Kamble, P., Deshmukh, P.R. and Garg, N. (2010) Metabolic Syndrome in Adult Population of Rural Wardha, Central India. Indian Journal Medical Research, 132, 701-705.
[20] Prabhakaran, D., Pankaj, S., Vivek, C., Lakshmy, R., Ajay, M. and Srinath, R.K. (2005) Cardiovascular Risk Factor Prevalence among Men in a Large Industry of Northern India. The National Medical Journal of India, 18, 59-65.
[21] Gharipour, M., Sarrafzadegan, N., Sadeghi, M., Andalib, E., Talaie, M., Shafie, D. and Aghababaie, E. (2013) Predictors of Metabolic Syndrome in Iranian Population: Waist Circumference, Body Mass Index or Waist to Hip Ratio? Cholesterol, 2013, Article ID: 198384.
[22] Frisard, M.I., Rood, J.C., Fang, X., Su, J., Welsh, D.A., Jazwinski, S.M. and Ravussin, E. (2009) Metabolic Syndrome and Risk Factors for Cardiovascular Disease: Are Nonagenarians Protected? Age (dordr), 31, 67-75.
[23] Jesmin, S., Islam, R., Islam, S., Mia, S., Sultana, S.N. and Zaedi, S. (2012) Comprehensive Assessment of Metabolic Syndrome among Rural Bangladeshi Women. BioMed Central Public Health, 12, 49.
[24] Moebus, S., Hanisch, J.U., Aidelsburger, P., Bramlage, P., Wasem, J. and J?ckel, K.H. (2007) Impact of 4 Different Definitions Used for the Assessment of the Prevalence of the Metabolic Syndrome in Primary Healthcare: The German Metabolic and Cardiovascular Risk Projects (GEMCAS). Cardiovascular Diabetology, 6, 22.
[25] Mensah, G.A., Mokdad, A.H., Ford, E., Narayan, K.M., Giles, W.H., Vinicor, F. and Deedwania, P.C. (2004) Obesity, Metabolic Syndrome, and Type 2 Diabetes: Emerging Epidemics and Their Cardiovascular Implications. Cardiology Clinics, 22, 485-504.
[26] Enas, E.A., Mohan, V., Deepa, M., Farooq, S., Pazhoor, S. and Chennikkara, H. (2007) The Metabolic Syndrome and Dyslipidemia among Asian Indians: A Population with High Rates of Diabetes and Premature Coronary Artery Disease. Journal of the Cardiometabolic Syndrome, 2, 267-275.
[27] Bengtsson, C., Lapidus, L., Stendahal, C. and Waldenst?rm, J. (2002) Hyperuricemia and Risk of Cardiovascular Disease and Overall Death. A 12 Year Follow-Up of Participants in the Population Study of Women in Gothenburg, Sweden. Acta Medica Scandinavica, 224, 549-555.
[28] Cai, Z., Xu, X., Wu, X., Zhou, C. and Li, D. (2009) Hyperuricemia and the Metabolic Syndrome. Asia Pacific Journal Clinic Nutrition, 18, 81-87.
[29] Invitti, C., Maffeis, C., Giradini, L., Pontiggia, B., Mazzili, G., Girola, A., et al. (2006) Metabolic Syndrome in Obese Caucasian Children: Prevalence Using WHO-Derived Criteria and Association with Nontraditional Cardiovascular Risk Factors. International Journal of Obesity, 30, 627-633.
[30] Ridker, P.M., Buring, J.E. and Cook, N.R. (2003) C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women. Circulation, 107, 391-397.
[31] Langenberg, C., Bergstrom, J., Scheidt-Nave, C., Pfeilschifter, J. and Barrett-Connor, E. (2006) Cardiovascular Death and the Metabolic Syndrome. Role of Adiposity-Signaling Hormones and Inflammatory Markers. Diabetes Care, 29, 1363-1369.
[32] Wald, D.S., Law, M. and Morris, J.K. (2002) Homocysteine and Cardiovascular Disease: Evidence on Causality from a Meta Analysis. BMJ, 325, 1202-1206.
[33] Ampara, V., Pilar, C., Natalia, B., Rafael, P., Antonio, H.M. and Dolores, C. (2011) Homocysteine Levels and the Metabolic Syndrome in a Mediterranean Population: A Case Control Study. Clinical Hemorheology and Microcirculation, 47, 59-66.
[34] Waldius, G. and Jungner, I. (2006) The ApoB/Apoa1 Ratio: A Strong, New Risk Factor for Cardiovascular Disease and a Target for Lipid-Lowering Therapy—A Review of the Evidence. Journal of Internal Medicine, 259, 493-519.
[35] Sierra-Johnson, J., Romero-Corral, J.A., Somers, V.K., Lopez-Jimenez, F., Walldius, G., Hamsten, A., et al. (2007) ApoB/ApoA-1 Ratio: An Independent Predictor of Insulin Resistance in US Non-Diabetic Subjects. European Heart Journal, 28, 2637-2643.
[36] Zhong, L., Li, Q., Jiang, Y., Cheng, D., Liu, Z., Wang, B., et al. (2010) The ApoB/ApoA1 Ratio Is Associated with Metabolic Syndrome and Its Components in a Chinese Population. Inflammation, 33, 353-358.
[37] Bazzano, L.A., Reynolds, K., Holder, K.N. and He, J. (2006) Effect of Folic Acid Supplementation on Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials. Journal of the American Medical Association, 296, 2720-2726.
[38] Sun, D.L., Wang, J.H., Jiang, B., Li, L.S., Li, L.S., Wu, L., Wu, H.Y. and He, Y. (2012) Metabolic Syndrome vs Its Components for Prediction of Cardiovascular Mortality: A Cohort Study in Chinese Elderly Adults. Journal of Geriatric Cardiology, 9, 123-129

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.